Scotiabank maintains Sector Outperform rating on Merck & Co, $180 price target
Scotiabank maintained their Sector Outperform rating on Merck & Co's stock with a price target of $180.00.The price target implies an upside of 21.1% from the Sep 28 close of $148.69.Key takeaways from the analyst noteStrong Immuno-Oncology Portfolio: Merck's leadership in the immuno-oncology space…